Tales of Transformation: Recent Episodes
Deloitte US
Tales of transformation is a Deloitte podcast series that explores trends transforming life sciences and health care. From emerging technologies to the rise of the empowered health care customer to the shift from volume to value, this series takes you to the intersection of change where tremendous transformation is happening. Tune in to stay a step ahead of the tremendous change happening in the industry.
Delve into the world of cell and gene therapies, where precision medicine meets complex supply chains and high-risk production. In this episode, industry experts discuss the challenges and opportunities arising from cell and gene manufacturing—and how organizations can better navigate the multi-stakeholder landscape by utilizing digital technologies. Tune in for insights to help you reshape the future of personalized medicine.
This episode of Tales of Transformation examines how artificial intelligence is a key next step in the evolution of life sciences and healthcare companies towards the future of health.
This episode of Tales of Transformation examines health equity and ways the health care ecosystem is working together to address social, economic, and environmental drivers
This episode of Tales of Transformation explores the renewed focus on the global behavioral health crisis in response to the pandemic and how digital engagement and partnerships can improve outcomes.
This episode of Tales of transformation explores the future of health spending and its dramatic transformation driven by new business models, emerging technologies, and engaged customers
This episode of Tales of transformation explores the impact that health tech innovation has had on traditional health care incumbents and its role in the future of health post-pandemic.
How can life sciences organizations start shifting away from today’s silos to reach the connected future of health?
Hear what health care organizations are already doing to improve connectivity and some of the biggest challenges that could prevent the industry from achieving radical interoperability.
Tune in to hear why organizations should use upcoming regulations as a jumping off point to develop and implement a strategic interoperability plan.
How will radically interoperable data increase collaboration across the health care ecosystem? And what does “radical interoperability” actually mean? Tune in to find out.
Tune in as we explore how health care organizations can integrate risk into their strategic decisions and take advantage of opportunities in the future of health.
While the future of health does introduce new risks, opportunities abound for organizations who can get in front of these risks and make smart changes to their business models.
Connected data will play a huge role in the future of health—and will bring new opportunities to life sciences and health care organizations. But what risks will they need to be on the lookout for?
Tune in as we kick off season four to explore how your life sciences and health care organization can stay ahead of emerging risks in the industry.
Consumer engagement in life sciences and health care continues to grow, from searching for care and accessing new channels of care to tracking and sharing health data and using new digital tools and technologies. How could this increased engagement spill over to the regulatory environment? Or will it?
The life sciences sector already operates in one of the most regulated industries in the world. The pace of technological advancement, including the emergence of new digital health products, is adding to this complexity, and in some cases, leading to some uncertainty regarding regulators’ expectations and requirements. How will industry regulations evolve to address emerging technologies and digital capabilities?
Digital Technologies are disrupting organizations of every size and shape, leaving many executives scrambling to find and assess the new technologies that will help their organizations compete now and in the future. Life science companies are no exception. However, while the technology itself is vital to digital transformation, the importance of strong leadership and culture cannot be overlooked. What roles do leadership and culture play in helping life sciences organizations move from simply doing digital to being digital?
New technologies and digital transformation offer biopharmaceutical and medtech companies opportunities across their organizations—from how they conduct research and interact with regulators to how they optimize their finance, supply chains, and manufacturing operations. New digital capabilities can also change the game in how companies engage with their customers, patients, and other stakeholders. However, life sciences companies have not traditionally been early adopters of new technologies. What is holding life sciences companies back? How can they better take advantage of new digital capabilities? And how do they demonstrate impact and ROI from their investments?
The final episode of season two explores the topic of “radical interoperability” and how players across the life sciences and health care industry can work together to create a more connected ecosystem.
This episode explores the biggest trends and technologies disrupting life sciences and health care and driving the industry toward a radically different future.
Tomorrow’s health care consumer won’t accept today’s limitations. In this episode, we explore how consumers are becoming increasingly influential in driving industry change.
The future of health will be defined by radically interoperable data, open yet secure platforms, and consumer-driven care. Tune in to this episode to hear more about the large-scale disruption about to hit life sciences and health care.
This episode explores how data and analytics could revolutionize the life sciences and health care industry and transform the future of care.
This episode explores how emerging technologies and automation are transforming core, back-office processes for life sciences and health care companies—and the potential benefits of an automated organization.
This episode dives into the concept of a “no-collar” workforce, where organizations increasingly rely on automation and emerging technologies, allowing employees to spend more of their time on value-added work.
Blockchain in life sciences and health care: are we looking at a revolution or an evolution? This episode takes a more holistic view of how blockchain can break down industry silos and enable collaboration, coordination, and connectivity across life sciences and health care stakeholders. Learn about the opportunity for blockchain to link the industry around the spectrum of care.
Blockchain is no longer the new technology kid on the block, but has its potential been fully realized? Or are we barely scratching the surface? What are the possibilities for blockchain – or blockchains – across the life sciences and health care industry?
What if a patient could put aside pamphlets and actually see the impact a diet could have on his or her state of health? What if a surgeon could train or prepare for a complex procedure by simulating it first in a 360-degree 3D simulation? Digital reality is no longer only a concept attributed to the science fiction realm. The immersive technology of augmented and virtual reality is now being applied to many business applications across industries, making these scenarios increasingly realistic. Explore the potential for digital reality in life sciences and health care.